BMO Capital downgraded Dow Inc. (DOW) to Underperform from Market Perform with a price target of $22, down from $29. The “significant weakness” across the company’s end markets resulting in soft pricing and lower volumes is likely to result in “severely challenged” Q2 EBITDA and second half of the year estimates “coming solidly lower,” the analyst tells investors in a research note. The firm says that looking at 2026, barring a change in the macro environment or significant supply closure, Dow’s 2026 EBITDA is set to come in $1B below consensus estimates. “With no end in sight for these anemic earnings levels, there appears a heightened risk Dow may cut the dividend,” the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOW:
- Dow Inc Faces Sell Rating Amid Weak Market Dynamics and Projected EBITDA Decline
- Dow Inc. downgraded to Hold from Buy at Fermium Research
- Dow Inc. files automatic mixed securities shelf
- Dow Inc Wins CAD $1.62 Billion Court Ruling
- Canadian court orders Nova Chemicals to pay Dow Inc. additional C$1.62B